Numerous clinical studies showed that high KRT7 levels are closely associated with poor prognosis in various types of cancer [20–24, 28–37], and KRT7 has been widely used as a diagnostic and prognostic biomarker in various types of malignant tumor [20–24, 28–37]. The gene discussed is KRT7; the disease is cancer.